POZ Community Forums
Main Forums => AIDS Activism => Topic started by: Jim Allen on January 29, 2020, 10:49:31 am
-
POZ.com full write-up:
https://www.poz.com/article/pharma-bro-martin-shkreli-headed-court
In short:
Martin Shkreli, the former pharmaceutical CEO who became notorious for spiking the price of the AIDS-related med Daraprim by 5,000%, is facing a new lawsuit, this one accusing him and his company of running an anticompetitive scheme.
The new lawsuit alleges that after Vyera jacked up the price of Daraprim, it blocked competitors from offering generic versions. For example, Vyera did not allow other companies to obtain samples and ingredients needed to make the drug.
Shkreli’s lawyer, Benjamin Brafman, told the Times that the accusations against Shkreli are “baseless.”
-
That guy must be one of the lowest forms of life that exists. I saw his comments at the time, along the lines of if they need the drugs to live they will find a way to pay for them. And his main concern was the company share holders.
I can see the need for companies to make a profit but he is an example of pure greed.